Archive Newsletter
-
02.23.24 -- Find Cell And Gene Therapy Supply Chain Support
2/23/2024
02/23/24 Cell & Gene Newsletter
-
02.22.24 -- Efficiently And Safely Manufacture Cell & Gene Therapies
2/22/2024
02/22/24 Cell & Gene Newsletter
-
02.22.24 -- Kriya Therapeutics' Announcements At JPM
2/22/2024
02/22/24 Cell & Gene Newsletter
-
02.21.24 -- Creative Solutions To Optimize Cold Chain Logistics
2/21/2024
02/21/24 Cell & Gene Newsletter
-
02.20.24 -- Mapping The Clinical Trial Terrain
2/20/2024
02/20/24 Cell & Gene Newsletter
-
02.20.24 -- 2024's Market Outlook For CGT
2/20/2024
02/20/24 Cell & Gene Newsletter
-
02.19.24 -- Overcome Regulatory Challenges Facing CGTs
2/19/2024
02/19/24 Cell & Gene Newsletter
-
02.19.24 -- FDA Issues Draft Guidance For CGT Potency Assurance
2/19/2024
02/19/24 Cell & Gene Newsletter
-
02.15.24 -- Bioprocess Innovations For The Development Of Cell And Gene Therapies
2/15/2024
02/15/24 Cell & Gene Newsletter
-
02.15.24 -- Gene Editing Versus Gene Therapy: Is There A Difference?
2/15/2024
02/15/24 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more